Member of the Association of American Physicians
C. Michael Stein mainly investigates Internal medicine, Endocrinology, Retrospective cohort study, Pharmacology and Cohort study. His Internal medicine research incorporates themes from Gastroenterology, Lupus erythematosus and Surgery. His Endocrinology research incorporates elements of Bioavailability, Midazolam and Polymorphism.
The study incorporates disciplines such as Clinical trial, Intensive care medicine and Hazard ratio in addition to Retrospective cohort study. He has researched Pharmacology in several fields, including Biological activity and Digoxin. The concepts of his Cohort study study are interwoven with issues in Platelet aggregation inhibitor and Cohort.
His main research concerns Internal medicine, Endocrinology, Rheumatoid arthritis, Pharmacology and Retrospective cohort study. The Internal medicine study combines topics in areas such as Gastroenterology and Cardiology. His studies deal with areas such as Agonist, Receptor and Adrenergic receptor as well as Endocrinology.
His work in Rheumatoid arthritis addresses subjects such as Coronary atherosclerosis, which are connected to disciplines such as Framingham Risk Score and Vascular disease. The various areas that C. Michael Stein examines in his Pharmacology study include Pharmacogenetics and VKORC1. His research in Retrospective cohort study intersects with topics in Anesthesia, Cohort study, Opioid, Hazard ratio and Cohort.
C. Michael Stein mainly focuses on Internal medicine, Retrospective cohort study, Odds ratio, Rheumatoid arthritis and Cohort study. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Cardiology. His work deals with themes such as Anesthesia, Incidence, Opioid, Hazard ratio and Medical prescription, which intersect with Retrospective cohort study.
His Odds ratio research integrates issues from Kidney disease, Renal function, Case-control study, Kidney and Dialysis. His Rheumatoid arthritis research is multidisciplinary, incorporating perspectives in Arthritis, Real-time polymerase chain reaction, Coronary atherosclerosis, microRNA and Rheumatology. His Cohort study study combines topics from a wide range of disciplines, such as Rate ratio and Sepsis.
Internal medicine, Retrospective cohort study, Odds ratio, Cohort and Cohort study are his primary areas of study. He combines Internal medicine and Upper gastrointestinal bleeding in his studies. His Retrospective cohort study research includes themes of Anesthesia, Medical prescription and Opioid.
C. Michael Stein usually deals with Odds ratio and limits it to topics linked to Case-control study and Type 2 diabetes, Cross-sectional study, Body mass index and Pediatrics. His research investigates the connection between Cohort and topics such as Genetic model that intersect with issues in Apolipoprotein B, Minor allele frequency, Imputation and Genotype. As part of one scientific family, C. Michael Stein deals mainly with the area of Cohort study, narrowing it down to issues related to the Rate ratio, and often Propoxyphene, Hydrocodone and Case series.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death
Wayne A. Ray;Cecilia P. Chung;Katherine T. Murray;C. Michael Stein.
The New England Journal of Medicine (2009)
Azithromycin and the risk of cardiovascular death.
Wayne A. Ray;Katherine T. Murray;Patrick G. Arbogast;C. Michael Stein.
The New England Journal of Medicine (2012)
Premature coronary-artery atherosclerosis in systemic lupus erythematosus.
Yu Asanuma;Annette Oeser;Ayumi K. Shintani;Elizabeth Turner.
The New England Journal of Medicine (2003)
New drugs for rheumatoid arthritis.
Nancy J. Olsen;C. Michael Stein.
The New England Journal of Medicine (2004)
Genetic determinants of response to warfarin during initial anticoagulation.
Ute I. Schwarz;Marylyn D. Ritchie;Yuki Bradford;Chun Li.
The New England Journal of Medicine (2008)
Molecular basis of ethnic differences in drug disposition and response.
Hong-Guang Xie;Richard B Kim;Alastair Jj Wood;C Michael Stein.
Annual Review of Pharmacology and Toxicology (2001)
COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease.
Wayne A Ray;Wayne A Ray;C Michael Stein;James R Daugherty;Kathi Hall.
The Lancet (2002)
Oral erythromycin and the risk of sudden death from cardiac causes
Wayne A Ray;Katherine T Murray;Sarah Meredith;Sukumar Suguna Narasimhulu.
The New England Journal of Medicine (2004)
Inhibition of P-Glycoprotein–Mediated Drug Transport A Unifying Mechanism to Explain the Interaction Between Digoxin and Quinidine
Martin F. Fromm;Richard B. Kim;C. Michael Stein;Grant R. Wilkinson.
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
Gregory M. Cooper;Julie A. Johnson;Taimour Y. Langaee;Hua Feng.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: